Acasti Pharma Inc (ACST)
2.928
+0.03
(+0.98%)
USD |
NASDAQ |
Apr 25, 16:00
2.92
-0.01
(-0.29%)
After-Hours: 20:00
Acasti Pharma Cash from Operations (TTM): -13.57M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -13.57M |
| September 30, 2023 | -15.40M |
| June 30, 2023 | -16.73M |
| March 31, 2023 | -15.91M |
| December 31, 2022 | -15.73M |
| September 30, 2022 | -16.59M |
| June 30, 2022 | -19.26M |
| March 31, 2022 | -17.23M |
| December 31, 2021 | -15.85M |
| September 30, 2021 | -15.48M |
| June 30, 2021 | -13.55M |
| March 31, 2021 | -14.32M |
| December 31, 2020 | -15.46M |
| September 30, 2020 | -18.35M |
| June 30, 2020 | -20.30M |
| March 31, 2020 | -22.95M |
| December 31, 2019 | -28.58M |
| September 30, 2019 | -28.30M |
| June 30, 2019 | -27.33M |
| March 31, 2019 | -24.79M |
| December 31, 2018 | -19.47M |
| September 30, 2018 | -16.13M |
| June 30, 2018 | -12.71M |
| March 31, 2018 | -9.694M |
| December 31, 2017 | -7.770M |
| Date | Value |
|---|---|
| September 30, 2017 | -4.961M |
| June 30, 2017 | -4.828M |
| November 30, 2016 | -4.762M |
| August 31, 2016 | -4.673M |
| May 31, 2016 | -5.664M |
| February 29, 2016 | -4.851M |
| November 30, 2015 | -5.411M |
| August 31, 2015 | -6.053M |
| May 31, 2015 | -6.068M |
| February 28, 2015 | -5.753M |
| November 30, 2014 | -8.150M |
| August 31, 2014 | -7.119M |
| May 31, 2014 | -5.666M |
| February 28, 2014 | -6.116M |
| November 30, 2013 | -1.824M |
| August 31, 2013 | -1.598M |
| May 31, 2013 | -2.769M |
| February 28, 2013 | -2.490M |
| November 30, 2012 | -4.059M |
| August 31, 2012 | -6.623M |
| May 31, 2012 | -5.854M |
| February 29, 2012 | -5.648M |
| November 30, 2011 | -4.510M |
| August 31, 2011 | -2.611M |
| May 31, 2011 | -2.206M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-28.58M
Minimum
Dec 2019
-13.55M
Maximum
Jun 2021
-18.47M
Average
-16.59M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
| Aurinia Pharmaceuticals Inc | -33.46M |
| Edesa Biotech Inc | -6.252M |
| Lexaria Bioscience Corp | -5.209M |
| Xenon Pharmaceuticals Inc | -145.33M |
| ESSA Pharma Inc | -22.19M |